Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Evogene ( (EVGN) ).
On February 5, 2025, Evogene Ltd. attempted to hold its Special General Meeting of Shareholders, but it was adjourned due to a lack of quorum. The meeting was rescheduled for February 12, 2025, at the company’s executive offices in Rehovot, Israel. This adjournment may influence the company’s operations and decision-making processes, highlighting potential challenges in shareholder engagement.
More about Evogene
Evogene Ltd. operates in the biotechnology industry, focusing primarily on the development of computational predictive biology solutions to enhance agricultural productivity and performance. It is based in Rehovot, Israel.
YTD Price Performance: -24.23%
Average Trading Volume: 69,578
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $7.89M
Find detailed analytics on EVGN stock on TipRanks’ Stock Analysis page.